Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
139.2 USD | +0.67% |
|
+3.61% | +5.62% |
Jul. 03 | ANALYST RECOMMENDATIONS : Alphabet, Nike, Nvidia, Tesla, Starbucks... | ![]() |
Jul. 03 | Neurocrine Biosciences Insider Sold Shares Worth $1,401,864, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.62% | 13.91B | |
+16.61% | 121B | |
+17.75% | 110B | |
+17.23% | 25.98B | |
-24.11% | 19.27B | |
-18.56% | 15.99B | |
-18.47% | 15.66B | |
-47.75% | 14.5B | |
+57.35% | 14.47B | |
+125.88% | 10B |
- Stock Market
- Equities
- NBIX Stock
- News Neurocrine Biosciences, Inc.
- RBC Raises Price Target on Neurocrine Biosciences to $129 From $121, Keeps Sector Perform Rating